Archana Ajmera, MSN, ANP-BC, is an Adult Nurse Practitioner at UC San Diego Health and a recognized expert in the supportive care and management of patients with genitourinary cancers. Based in Los Angeles, she has dedicated her career to improving patient outcomes by optimizing treatment delivery, managing complex toxicities, and ensuring continuity of care throughout the cancer journey.
At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Ms. Ajmera will present on “Management of IO/TKI Toxicity: Frontline Treatment Strategies for Advanced Disease.” Her session will highlight the essential role of toxicity management in maximizing the benefits of frontline immunotherapy (IO) and tyrosine kinase inhibitor (TKI)–based regimens for advanced renal cell carcinoma (RCC).
Ms. Ajmera will discuss
-
Recognition and early intervention in managing IO- and TKI-related adverse events.
-
Best practices in toxicity management to maintain treatment continuity without compromising safety.
-
Multidisciplinary strategies that integrate nursing expertise into frontline care planning.
By focusing on proactive management of toxicities, Ms. Ajmera emphasizes that successful frontline treatment is not only about selecting the right therapy, but also ensuring patients can stay on therapy long enough to derive its full benefit.
Global Voices in Renal Oncology (VIRO) 2025
